Literature DB >> 25203203

Decoys and cardiovascular development: CXCR7 and regulation of adrenomedullin signaling.

Kelly L Betterman1, Natasha L Harvey2.   

Abstract

Decoy receptors have ligand binding capacity but, in contrast to cognate receptors, do not initiate typical downstream signaling cascades. In this issue of Developmental Cell, Klein and colleagues (2014) demonstrate that CXCR7 acts as a decoy receptor for adrenomedullin, a peptide hormone with key roles in cardiovascular development.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25203203     DOI： 10.1016/j.devcel.2014.08.021

Source DB:  PubMed          Journal:  Dev Cell        ISSN： 1534-5807            Impact factor:   12.270


  5 in total

Review 1.  Adrenomedullin in lymphangiogenesis: from development to disease.

Authors:  Klara R Klein; Kathleen M Caron
Journal:  Cell Mol Life Sci       Date:  2015-05-08       Impact factor: 9.261

Review 2.  CXCR7 Targeting and Its Major Disease Relevance.

Authors:  Chuan Wang; Weilin Chen; Jianzhong Shen
Journal:  Front Pharmacol       Date:  2018-06-21       Impact factor: 5.810

3.  Lymphatic endothelial-cell expressed ACKR3 is dispensable for postnatal lymphangiogenesis and lymphatic drainage function in mice.

Authors:  Elena C Sigmund; Lilian Baur; Philipp Schineis; Jorge Arasa; Victor Collado-Diaz; Martina Vranova; Rolf A K Stahl; Marcus Thelen; Cornelia Halin
Journal:  PLoS One       Date:  2021-04-15       Impact factor: 3.240

Review 4.  Role and implications of the CXCL12/CXCR4/CXCR7 axis in atherosclerosis: still a debate.

Authors:  Hussam A S Murad; Misbahuddin M Rafeeq; Thamer M A Alqurashi
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

Review 5.  Atypical Roles of the Chemokine Receptor ACKR3/CXCR7 in Platelet Pathophysiology.

Authors:  Madhumita Chatterjee
Journal:  Cells       Date:  2022-01-09       Impact factor: 6.600
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.